Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ technology to make permanent alterations to the human genome, aiming to cure diseases and advance genome engineering.
Ohio
Notice Date
January 12, 2026
March 8, 2026
Unavailable
Permanent
Layoff
More WARN Notices from
